enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Pertuzumab/trastuzumab/hyaluronidase - Wikipedia

    en.wikipedia.org/wiki/Pertuzumab/trastuzumab/...

    The fixed-dose combination of pertuzumab, trastuzumab, and hyaluronidase was approved for medical use in the United States in June 2020. [5] [10]The FDA's approval was based on the results of a non-inferiority study in participants with HER2-positive early breast cancer, which demonstrated the fixed-dose combination of pertuzumab, trastuzumab, and hyaluronidase had comparable efficacy and ...

  3. Trastuzumab/hyaluronidase - Wikipedia

    en.wikipedia.org/wiki/Trastuzumab/hyaluronidase

    Trastuzumab/hyaluronidase, sold under the brand name Herceptin SC among others, is a fixed-dose combination medication for the treatment of HER2-overexpressing breast ...

  4. Category:Combination cancer drugs - Wikipedia

    en.wikipedia.org/wiki/Category:Combination...

    Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more

  5. Pertuzumab - Wikipedia

    en.wikipedia.org/wiki/Pertuzumab

    Pertuzumab is administered as an intravenous infusion in combination with trastuzumab and docetaxel as a first line treatment for HER2-positive metastatic breast cancer. [4] [3] It is also used in the same combination as a neoadjuvant (given to reduce the size of a tumor, prior to surgery or radiation) for HER2-positive early breast cancer; as of 2016 this use had not been shown to increase ...

  6. Hyaluronidase - Wikipedia

    en.wikipedia.org/wiki/Hyaluronidase

    Elevated tissue expression of hyaluronic acid and hyaluronidase validates the hyaluronic acid-hyaluronidases urine test for bladder cancer. [48] Limited data support a role of lysosomal hyaluronidases in metastasis, while other data support a role in tumor suppression. Other studies suggest no contribution or effects independent of enzyme activity.

  7. Revumenib - Wikipedia

    en.wikipedia.org/wiki/Revumenib

    Revumenib, sold under the brand name Revuforj, is an anti-cancer medication used for the treatment of acute leukemias harboring lysine methyltransferase 2A gene (KMT2A) rearrangements. [1]

  8. ‘Latinos Break The Mold’ by Huffington Post

    testkitchen.huffingtonpost.com/latinos-break-the...

    Built with Readymag—a tool to design anything on the web.

  9. Category:Drugs developed by Hoffmann-La Roche - Wikipedia

    en.wikipedia.org/wiki/Category:Drugs_developed...

    Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more